The pharmacologic rationale for the clinical use of antidepressants.
Pinder
R M
RM
D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy / Q000523:psychology; D002986:Clinical Trials as Topic; D003866:Depressive Disorder / Q000188:drug therapy / Q000523:psychology; D005473:Fluoxetine / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008803:Mianserin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D000078785:Mirtazapine; D011569:Psychiatric Status Rating Scales; D011941:Receptors, Adrenergic / Q000187:drug effects; D011985:Receptors, Serotonin / Q000187:drug effects; D016896:Treatment Outcome
D000929:Antidepressive Agents, Tricyclic; D011941:Receptors, Adrenergic; D011985:Receptors, Serotonin; D005473:Fluoxetine; D008803:Mianserin; D000078785:Mirtazapine